These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 2833355

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Recognition of Rous sarcoma virus-induced tumor antigens by cytotoxic T lymphocytes (CTL): studies on specificity of killing by CTL employing H-2 congenic and recombinant mouse tumor cells.
    Haraguchi S, Kurakata S, Fujii T, Matsuo T, Yoshida TO.
    Cell Immunol; 1987 Apr 01; 105(2):340-54. PubMed ID: 2436809
    [Abstract] [Full Text] [Related]

  • 3. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M, Orosz CG, Bach FH.
    J Immunol; 1984 Jun 01; 132(6):3218-25. PubMed ID: 6202778
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Degradation of specificity in cytolytic T lymphocyte clones. The separate YAC-1-type (NK-like) and P815-type broad specificity killing patterns are both restricted to the larger cells within a clone but may be expressed independently in clones from different mouse strains.
    Shortman K, Wilson A.
    J Immunol; 1986 Aug 01; 137(3):798-804. PubMed ID: 2424983
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA, Ruscetti SK, Longo DL, Jacobson S, Brown EJ, Zinn S, Kruisbeek AM.
    J Immunol; 1985 Jul 01; 135(1):703-13. PubMed ID: 2582053
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
    Azuma H, Phillips JD, Green WR.
    J Immunol; 1987 Oct 01; 139(7):2464-73. PubMed ID: 2821116
    [Abstract] [Full Text] [Related]

  • 15. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. I. Isolation of a selectively resistant variant tumor subclone.
    Green WR.
    Eur J Immunol; 1983 Nov 01; 13(11):863-70. PubMed ID: 6196206
    [Abstract] [Full Text] [Related]

  • 16. Somatic H-2Kk variants reveal nonidentity of serological and cytotoxic T cell-defined Kk determinants.
    Vohr HW, Holtkamp B, Rajewsky K.
    Eur J Immunol; 1983 Oct 01; 13(10):846-51. PubMed ID: 6196205
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. V. Recognition is restricted to gene products encoded by the viral S RNA segment.
    Riviere Y, Southern PJ, Ahmed R, Oldstone MB.
    J Immunol; 1986 Jan 01; 136(1):304-7. PubMed ID: 3484391
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin.
    Green LM, Reade JL, Ware CF, Devlin PE, Liang CM, Devlin JJ.
    J Immunol; 1986 Dec 01; 137(11):3488-93. PubMed ID: 2431035
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.